CELU - Celularity Inc - Ordinary Shares - Class A
Previous close
2.988
0 0%
Share volume: 6,230
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.99
0.00
0.00%
Summary score
27%
Profitability
0%
Dept financing
18%
Liquidity
7%
Performance
62%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2019 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-48.94%
Return on assets
-7.36%
Return on sales
-721.6%
Return on invested capital
-24.76%
Total debt ratio
64.8%
Debt ratio change over timeo
5.42%
Current Ratio
0.97%
Quick Ratio
0.75%
Cash Position Ratio
0.5%
Short-term ratios 31-Dec-2022 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-92.16%
Return on assets
-6.02%
Return on sales
-590.43%
Return on invested capital
-50.9%
Total debt ratio
65.32%
Debt ratio change over timeo
-1.23%
Current Ratio
0.29%
Quick Ratio
0.21%
Cash Position Ratio
0.05%
Last quarter ratios 31-Dec-2023
The data are presented for the financials results of the last quarter.
Return on equity
23.31%
Return on assets
9.25%
Return on sales
109.93%
Return on invested capital
16.81%
Total debt ratio
71.53%
Debt ratio change over time
3.26%
Current Ratio
0.29%
Quick Ratio
0.21%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 31-Dec-2019 - 31-Dec-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
177.06%
Return on assets
-173.09%
Return on sales
-9134.35%
Return on invested capital
55.13%
Total debt ratio
542.22%
Debt ratio change over time
5.42%
Current Ratio
20.63%
Quick Ratio
14.17%
Cash Position Ratio
10.47%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CELU | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -48.94% | 10.2% | 35.82% | 7.59% |
| Return on assets | -7.36% | 2.89% | 3.31% | 5.76% |
| Return on sales | -721.6% | 29.84% | 34.06% | 41.2% |
| Return on invested capital | -24.76% | 3.06% | 5.78% | 20.17% |
| Profitability | 0% | 42% | 67% | 80% |
| Total debt ratio | 64.8% | 91.31% | 89.91% | 26.84% |
| Debt ratio change over time | 5.42% | 295.05% | -10.03% | 1.11% |
| Dept financing | 18% | 50% | 25% | 7% |
| Current Ratio | 0.29% | 0.92% | 2.61% | 5.44% |
| Quick Ratio | 0.21% | 0.8% | 2.24% | 4.68% |
| Cash Position Ratio | 0.05% | 0.31% | 1.72% | 2.92% |
| Liquididy | 17% | 18% | 34% | 75% |
| Short-term ratios | CELU | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -92.16% | 9.95% | 27.09% | 4.01% |
| Return on assets | -6.02% | 2.47% | 2.17% | 3.36% |
| Return on sales | -590.43% | 24.58% | 28.87% | 32.26% |
| Return on invested capital | -50.9% | 1.71% | 5.84% | 9.7% |
| Profitability | 0% | 51% | 79% | 79% |
| Total debt ratio | 65.32% | 91.02% | 92.9% | 21.89% |
| Debt ratio change over time | -1.23% | 107.3% | -84.55% | 1.71% |
| Dept financing | 18% | 49% | 25% | 6% |
| Current Ratio | 0.29% | 0.92% | 2.61% | 5.44% |
| Quick Ratio | 0.21% | 0.8% | 2.24% | 4.68% |
| Cash Position Ratio | 0.05% | 0.31% | 1.72% | 2.92% |
| Liquididy | 3% | 11% | 39% | 75% |